• Thumbnail for Janssen COVID-19 vaccine
    The Janssen COVID19 vaccine, (Ad26.COV2.S) sold under the brand name Jcovden, is a COVID19 vaccine that was developed by Janssen Vaccines in Leiden...
    141 KB (11,331 words) - 06:12, 24 September 2024
  • most COVID‑19 vaccines were two-dose vaccines, with the exception single-dose vaccines Convidecia and the Janssen COVID19 vaccine, and vaccines with three-dose...
    205 KB (23,333 words) - 06:21, 21 November 2024
  • Thumbnail for Pfizer–BioNTech COVID-19 vaccine
    The Pfizer–BioNTech COVID-19 vaccine, sold under the brand name Comirnaty, is an mRNA-based COVID-19 vaccine developed by the German biotechnology company...
    260 KB (22,097 words) - 23:43, 14 October 2024
  • Thumbnail for Embolic and thrombotic events after COVID-19 vaccination
    Oxford–AstraZeneca COVID19 vaccine (AZD1222) during the COVID19 pandemic. It was subsequently also described in the Janssen COVID19 vaccine (Johnson & Johnson)...
    53 KB (5,176 words) - 01:55, 16 July 2024
  • authorities have granted full or emergency use authorizations for 40 COVID-19 vaccines. Ten vaccines have been approved for emergency or full use by at least one...
    322 KB (19,558 words) - 03:33, 16 September 2024
  • Janssen Biotech, American biotechnology company Janssen COVID-19 vaccine, a COVID-19 vaccine Janssen Pharmaceuticals, a Belgian company USS Janssen (DE-396)...
    613 bytes (102 words) - 12:22, 24 May 2022
  • Thumbnail for Janssen Vaccines
    1655°N 4.4673°E / 52.1655; 4.4673 Janssen Vaccines, formerly Crucell, is a biotechnology company specializing in vaccines and biopharmaceutical technologies...
    5 KB (434 words) - 00:59, 12 November 2024
  • Thumbnail for History of COVID-19 vaccine development
    an outbreak and hasten the development of a preventive COVID-19 vaccine. Since 2020, vaccine development has been expedited via unprecedented collaboration...
    122 KB (11,033 words) - 06:12, 17 November 2024
  • Thumbnail for COVID-19 vaccine misinformation and hesitancy
    variety of unfounded conspiracy theories and other misinformation about COVID-19 vaccines have spread based on misunderstood or misrepresented science, religion...
    132 KB (12,911 words) - 03:13, 18 November 2024
  • the TGA to the Janssen COVID-19 vaccine, the third vaccine for potential use in Australia. Strict conditions were imposed on Janssen which includes further...
    31 KB (2,811 words) - 08:32, 16 November 2024
  • Thumbnail for COVID-19 vaccination in South Africa
    of the Janssen COVID-19 vaccine. On 27 February 2021, South Africa had received its second consignment of 80,000 doses of the Janssen vaccine. On 5 March...
    198 KB (13,219 words) - 03:24, 24 October 2024
  • Thumbnail for COVID-19 vaccination in the United States
    2020, and the Janssen (Johnson & Johnson) vaccine was granted emergency use authorization on February 27, 2021. It was not until April 19, 2021, that all...
    134 KB (10,719 words) - 20:36, 7 November 2024
  • authorizations (EUA) to 10 COVID-19 vaccines (in chronological order): Pfizer–BioNTech, Oxford–AstraZeneca, Sinovac, Sputnik V, Janssen, Covaxin, Moderna, Sinopharm...
    128 KB (9,955 words) - 00:32, 16 August 2024
  • Thumbnail for Oxford–AstraZeneca COVID-19 vaccine
    Oxford–AstraZeneca COVID19 vaccine, sold under the brand names Covishield and Vaxzevria among others, is a viral vector vaccine for the prevention of COVID-19. It was...
    214 KB (17,080 words) - 15:51, 27 September 2024
  • Thumbnail for COVID-19 vaccination in Africa
    Covishield vaccine provided through the COVAX pillar. On 25 July 2021, Liberia took delivery of 302,400 doses of the Janssen COVID-19 vaccine donated by...
    110 KB (11,862 words) - 22:35, 9 November 2023
  • Thumbnail for Sputnik V COVID-19 vaccine
    Gam-COVID-Vac (Russian: Гам-КОВИД-Вак, the name under which it is legally registered and produced) is an adenovirus viral vector vaccine for COVID-19 developed...
    154 KB (13,917 words) - 19:29, 18 November 2024
  • Thumbnail for COVID-19 vaccination in Vietnam
    vaccine was approved for emergency use on 4 June 2021, while Pfizer–BioNTech COVID-19 vaccine, Moderna COVID-19 vaccine and Janssen COVID-19 vaccine were...
    112 KB (8,523 words) - 08:21, 16 October 2024
  • Thumbnail for Sanofi–GSK COVID-19 vaccine
    Sanofi–GSK COVID-19 vaccine sold under the brand name VidPrevtyn Beta, is a COVID-19 vaccine developed by Sanofi Pasteur and GSK. The Sanofi–GSK COVID19 vaccine...
    19 KB (1,436 words) - 08:53, 24 September 2024
  • Thumbnail for Vaxart COVID-19 vaccine
    Vaxart COVID-19 vaccine is a COVID-19 vaccine candidate developed by Vaxart. "Patent Landscape Report COVID-19-related vaccines and therapeutics" (PDF)...
    2 KB (108 words) - 10:50, 24 September 2024
  • Thumbnail for Stemirna COVID-19 vaccine
    Stemirna COVID-19 vaccine is a COVID-19 vaccine candidate developed by Stemirna Therapeutics. "Patent Landscape Report COVID-19-related vaccines and therapeutics"...
    3 KB (113 words) - 09:01, 24 September 2024
  • Thumbnail for Deployment of COVID-19 vaccines
    53 billion COVID-19 vaccine doses have been administered worldwide, with 70.6 percent of the global population having received at least one dose. While 4.19 million...
    156 KB (13,918 words) - 21:34, 29 September 2024
  • Thumbnail for COVID-19 vaccine clinical research
    COVID-19 vaccine clinical research uses clinical research to establish the characteristics of COVID-19 vaccines. These characteristics include efficacy...
    98 KB (19,258 words) - 19:10, 20 November 2024
  • Infectious diseases therapies Edurant Intelence Prezcobix Symtuza Janssen COVID-19 vaccine Neuroscience therapies Concerta Invega Ponvory Risperdal Consta...
    25 KB (1,860 words) - 04:49, 26 July 2024
  • Thumbnail for Moderna COVID-19 vaccine
    The Moderna COVID19 vaccine, sold under the brand name Spikevax, is a COVID-19 vaccine developed by the American company Moderna, the United States National...
    177 KB (13,698 words) - 16:52, 23 October 2024
  • Thumbnail for Cerebral venous sinus thrombosis
    & Johnson COVID-19 Vaccine". Retrieved 13 April 2021. "FDA and CDC Lift Recommended Pause on Johnson & Johnson (Janssen) COVID-19 Vaccine Use Following...
    38 KB (4,413 words) - 16:32, 16 June 2024
  • Thumbnail for Aspen Pharmacare
    other products, Aspen has also been involved in manufacturing the Janssen COVID-19 vaccine through "fill and finish", and has the rights to sell the product...
    37 KB (3,561 words) - 21:59, 4 November 2024
  • Thumbnail for COVID-19 pandemic in Canada
    Oxford–AstraZeneca COVID-19 vaccine for use, and on March 5, 2021, they additionally approved the Janssen COVID-19 vaccine for a total of four approved vaccines in the...
    175 KB (14,698 words) - 05:57, 27 September 2024
  • Thumbnail for Johnson & Johnson
    "Johnson & Johnson Prepares to Resume Phase 3 ENSEMBLE Trial of its Janssen COVID-19 Vaccine Candidate in the U.S." Johnson & Johnson. October 23, 2020. Retrieved...
    116 KB (11,245 words) - 06:59, 17 November 2024
  • Thumbnail for Novavax COVID-19 vaccine
    The Novavax COVID-19 vaccine, sold under the brand names Nuvaxovid and Covovax, among others, is a subunit COVID-19 vaccine developed by Novavax and the...
    74 KB (5,621 words) - 06:11, 21 October 2024
  • Thumbnail for COVID-19 vaccination in Spain
    Pfizer–BioNTech COVID-19 vaccine doses, 16,105,300 Moderna vaccine doses, 17,427,500 Oxford–AstraZeneca vaccine doses and 2,659,000 Janssen vaccine doses, totaling...
    23 KB (1,005 words) - 20:37, 16 May 2024